Lapatinib Terminated Phase 2 Trials for HER2 Positive Esophagogastric Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer |